NCT00206063 - Long Term Open Follow-up With H376/95 vs. Warfarin | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

June 30, 2004

Study Completion Date

April 30, 2006

Conditions

Stroke Prevention in Patients With Atrial Fibrillation

Interventions

DRUG

EXANTA

Trial Locations (19)

Research Site, Palo Alto

Research Site, Oostduinkerke

Research Site, Helsingor

Research Site, Most

Research Site, Plzeo

Research Site, Poibram

Research Site, Prague

Research Site, Aarhus

Research Site, Odense

Research Site, Kuopio

Research Site, Savonlinna

Research Site, Hamar

Research Site, Oslo

Research Site, Płock

Research Site, Siedice

Research Site, Warsaw

Research Site, Lund

Research Site, Leicester

Research Site, Newcastle